540080
(S)-(+)-Epichlorohydrin
98%
동의어(들):
(S)-(+)-2-(Chloromethyl)oxirane
조직 및 계약 가격을 보려면 로그인를 클릭합니다.
크기 선택
보기 변경
제품정보 (DICE 배송 시 비용 별도)
실험식(Hill 표기법):
C3H5ClO
CAS 번호:
Molecular Weight:
92.52
UNSPSC Code:
12352005
NACRES:
NA.22
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
1420784
Assay:
98%
vapor density
3.2 (vs air)
vapor pressure
12.5 mmHg ( 20 °C)
assay
98%
optical activity
[α]20/D +35°, c = 1 in methanol
optical purity
ee: 97% (GLC)
autoignition temp.
1421 °F
expl. lim.
21 %
refractive index
n20/D 1.438 (lit.)
bp
92-93 °C/360 mmHg (lit.)
density
1.183 g/mL at 25 °C (lit.)
functional group
chloro, ether
SMILES string
ClC[C@@H]1CO1
InChI
1S/C3H5ClO/c4-1-3-2-5-3/h3H,1-2H2/t3-/m1/s1
InChI key
BRLQWZUYTZBJKN-GSVOUGTGSA-N
Application
Used in the total synthesis of Macquarimicins and in the total synthesis of the macrolide RK-397.
Used to synthesize inhibitors of fatty acid oxidation as potential metabolic modulators.
Chiral building block in the enantioselective syntheses of hydroxyisoxazolidines and (+)-cis-sylvaticin, a potential antitumor agent.
Legal Information
Manufactured under license by Sterling Pharma Solutions Limited, using Jacobsen HKR technology.
signalword
Danger
Hazard Classifications
Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Carc. 1B - Eye Dam. 1 - Flam. Liq. 3 - Skin Corr. 1B - Skin Sens. 1
저장 등급
3 - Flammable liquids
flash_point_f
89.6 °F - closed cup
flash_point_c
32 °C - closed cup
ppe
Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter
Ryosuke Munakata et al.
Journal of the American Chemical Society, 125(48), 14722-14723 (2003-12-04)
The first total synthesis of (+)-macquarimicin A (1), a novel inhibitor of neutral sphingomyelinase (N-SMase) with antiinflammatory activity, has been accomplished. The present work determined the absolute configuration of (+)-1 and revised the C(2)-C(3) geometry to be Z. The synthesis
Tetrahedron Letters, 47, 7635-7635 (2006)
Elfatih Elzein et al.
Bioorganic & medicinal chemistry letters, 14(4), 973-977 (2004-03-12)
We describe the synthesis of novel inhibitors of fatty acid oxidation as potential metabolic modulators for the treatment of stable angina. Replacement of the 2H-benzo[d]1,3-dioxolene ring system in our initial lead 3 with different benzthiazoles, benzoxazoles and introducing small alkyl